Discover Leading-Edge Technology, Hormone Diagnostic Tests, Anti-Inflammatory Products, and a CLIA-Approved Salivary Testing Laboratory at Clarion Research Group.
Clarion Research Group (CRG) is a translational research company offering the following innovative clinical products:
- CRGrafting™, our patented flagship product reduces the inflammatory response. With less inflammation, the bone can develop to a higher quality than it can with other currently available methods. This product is not currently available for distribution or approved for use by the FDA. Clarion Research Group is pursuing FDA clearance.
- Hormonal Clarity Diagnostics™ utilizes an innovative, accurate, noninvasive, salivary diagnostic at-home test kit to identify hormone levels for peri-/postmenopausal women and for men. HCD can precisely identify the bioavailable (active) hormones in your body instead of the protein-bound (inactive) hormones. With more accurate results, patients can confer with their doctors to correctly diagnose their hormonal health issues and determine a treatment plan that can improve their quality of life.
- VeinStay™ is patented and FDA-registered as a solution to more accurate venipunctures. In a recent clinical trial, VeinStay demonstrated a success rate of first venipuncture by more than 20%. Available through CRG.